Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Abigail Melake
US Food and Drug Administration
Poster(s):
(235) Analysis of Postapproval Pregnancy Safety Studies Associated with FDA Approved Products
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
(312) Sources and Characteristics of Quantitative Human Pregnancy Safety Data in U.S. FDA Approved Product Labeling, 2015-2021
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
